ILMN currently has a PEG ratio of 1.39. Another notable valuation metric for JAZZ is its P/B ratio of 2.01. The P/B is a method of comparing a stock's market value to its book value, which is ...

Episode 3: Our Language As the stock market continues to soar, jazz is everywhere in America, and now, for the first time soloists and singers take center stage, transforming the music with their ...

Get more of a good thing! Our weekly newsletter highlights our top stories, our special offers, and upcoming jazz events near you.

HC Wainwright currently has a “Buy” rating and a $217.00 target price on the stock. The consensus estimate for Jazz Pharmaceuticals’ current full-year earnings is $16.96 per share.